DONG-A ST CO.,LTD
Dong-A ST is a KOSPI-listed (170900) pharmaceutical company based in Seoul. Its obesity candidate DA-1726 is in a US Phase 1 study, and in 2026 the company began operating the AIDDP AI drug-discovery platform with its affiliate DAI.
| Headquarters | Seoul, South Korea |
|---|---|
| Listing | KOSPI:170900 |
| Lead asset / stage | DA-1726 Phase 1 — United States |
| Latest event | Dong-A ST and DAI announced operation of the AIDDP AI drug-discovery platform. |